ethinyl estradiol has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeva, OE; Gorbatov, SA; Kolokolova, MK; Kozlov, AS; Scherbakov, AM; Uvarov, DY; Volkova, YA; Zavarzin, IV | 1 |
| Coricovac, D; Dehelean, CA; Dobrescu, A; Draghici, GA; Malita, D; Marcovici, I; Navolan, D; Olaru, F; Simu, S | 1 |
2 other study(ies) available for ethinyl estradiol and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Steroidal N-Sulfonylimidates: Synthesis and biological evaluation in breast cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidoesters; MCF-7 Cells; Molecular Structure; Steroids; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2019 |
Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Signal Transduction; Triple Negative Breast Neoplasms | 2021 |